Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-19 Purchase | 2024-08-21 6:38 pm | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 38,924 | $0.62085 | $24,166 | 296,540 (Direct) | View |
| 2023-08-08 Purchase | 2023-08-09 6:21 pm | Quince Therapeutics Inc. | QNCX | Hannah Brendan Chief Business Officer | 71,762 | $1.22 | $87,550 | 201,555 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-04 Exercise | 2024-06-05 2:37 pm | N/A 2032-03-27 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 56,061 | $0 | 305,055 (Direct) | View |
| 2024-06-04 Exercise | 2024-06-05 2:37 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 56,061 | $0.55 | 305,055 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 5:53 pm | N/A 2034-01-31 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 600,000 | $0 | 600,000 (Direct) | View |
| 2023-10-24 Option Award | 2023-10-26 5:54 pm | N/A 2033-10-23 | Quince Therapeutics Inc. | QNCX | Hannah Brendan Chief Business Officer and COO | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:29 pm | N/A 2033-01-31 | Quince Therapeutics Inc. | QNCX | Hannah Brendan Chief Business Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2022-05-19 Option Award(A) | 2022-05-27 5:34 pm | N/A N/A | Cortexyme Inc. | CRTX | Hannah Brendan Chief Business Officer | 113,569 | $0 | 129,793 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-23 8:07 pm | N/A 2032-03-27 | Cortexyme Inc. | CRTX | Hannah Brendan Chief Business Officer | 473,380 | $0 | 473,380 (Direct) | View |